Israel Active

Scientists at Israel’s Bar-Ilan University have found that malignant cells in hematologic cancer (leukemia, lymphoma, and multiple myeloma etc.), rely on a cytoskeletal protein, called WASp. Attacking WASp can destroy malignant cells without threatening healthy ones.

Israel has seen the biggest drop in coronavirus morbidity anywhere in the world, according to global trackers. Covid-19 may be here to stay, but thanks to boosters, virus-killing masks, nasal sprays, and vaccine passports, Israel has only some 5,500 active cases (115 serious).

Very interesting article about Israel’s NanoScent (see previously), which has developed a device so sensitive that it can detect viruses in the breath, such as SARS-Cov2. 50% of employees are female and it is another example of Christian Arabs, Muslims, and Israeli Jews working side by side.

Israel’s Enovid (see previously) is ramping up production of its SaNOtize anti-Covid Nasal spray to keep up with demand. It is to manufacture up to 250,000 units per month in the US alone. In August, Enovid struck a deal with India’s Glenmark to manufacture the spray for South-East Asia.

Israel’s Aidoc, (see previously) has been selected the “Best New Health Application” award of the University of California San Francisco (UCSF) Health Awards competition. Aidoc’s artificial intelligence (AI) solutions have revolutionized medical imaging.

The Canadian-Israeli Azrieli Foundation has given NIS 40 million ($13 million) to the National Autism Research Centre of Israel in BeerSheba (see previously). It is the largest ever donation for an autism infrastructure project in Israel.

Israel’s Geneyx Genomex utilizes the world’s largest unified global knowledge base for interrogating genetic-based diseases and disorders. It provides fast analysis, interpretation, and reporting to help labs accelerate the development of targeted and personalized therapeutics.

Israel’s Algamed is using natural-based compounds made from algae plus its own innovative FemTech to treat sensitive feminine conditions. The algae excretes a gel that keeps it moist, and has numerous anti-bacterial, anti-inflammatory, antiviral, and anti-aging benefits.

Israel’s BioLight (see previously) is partnering with Tel Aviv’s Sourasky (Ichilov) Medical Center, to locate and develop innovative technologies in ophthalmology. Also, Biolight’s subsidiary Diagnostear has begun a clinical trial in India of its diagnosis of Dry Eye Disease.

Israel’s Neuromagen is developing a new class of small molecules to treat ALS (Amyotrophic Lateral Sclerosis - Lou Gehrig’s Disease), and other neurodegenerative diseases. The molecules activate the enzyme telomerase reverse transcriptase, which protects and rehabilitates neuronal cells.